There are several groups of drugs for the treatment of T2DM, and they differ in the mechanism of action: Suppressing hepatic glucose output, stimulating insulin release, mitigating glucose absorption, and increasing peripheral glucose utilization [4]. The gene discussed is INS; the disease is type 2 diabetes mellitus.